Diagnostic criteria for spinal muscular atrophy 5q
Background. The variety of phenotypic manifestations of spinal muscular atrophy 5q (5qCMA) is the reason for the difficulty in diagnosing and delaying the diagnosis, which is of particular importance today due to the emergence of new etiopathogenetic therapeutic possibilities.Objective: determinatio...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2021-12-01
|
| Series: | Нервно-мышечные болезни |
| Subjects: | |
| Online Access: | https://nmb.abvpress.ru/jour/article/view/460 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849403593209151488 |
|---|---|
| author | I. V. Sharkova E. L. Dadali S. S. Nikitin |
| author_facet | I. V. Sharkova E. L. Dadali S. S. Nikitin |
| author_sort | I. V. Sharkova |
| collection | DOAJ |
| description | Background. The variety of phenotypic manifestations of spinal muscular atrophy 5q (5qCMA) is the reason for the difficulty in diagnosing and delaying the diagnosis, which is of particular importance today due to the emergence of new etiopathogenetic therapeutic possibilities.Objective: determination of the main clinical features and symptoms of 5qCMA with onset at different age periods, and the development of an algorithm that can help in making decisions regarding the need for testing the SMN1 gene by primary care and hospital doctors.Materials and methods. A retrospective analysis of the case histories of patients observed at the Research Center of Medical Genetics with a confirmed diagnosis of 5qCMA was carried out.Results. The study included data from 315 patients, including: 173 with type I, 95 and 47 with types II and III 5qCMA. In all cases, the presence and diagnostic significance of 27 signs and symptoms were analyzed, depending on the age of disease manifestation. An attempt was made to isolate the main symptoms, which are the basis for the mandatory exclusion of 5qCMA by molecular genetic methods in patients with the onset of the disease before and after 18 months of life. |
| format | Article |
| id | doaj-art-4e9fcc84d7bc4791b08802fdb4c6a658 |
| institution | Kabale University |
| issn | 2222-8721 2413-0443 |
| language | Russian |
| publishDate | 2021-12-01 |
| publisher | ABV-press |
| record_format | Article |
| series | Нервно-мышечные болезни |
| spelling | doaj-art-4e9fcc84d7bc4791b08802fdb4c6a6582025-08-20T03:37:12ZrusABV-pressНервно-мышечные болезни2222-87212413-04432021-12-01113374410.17650/2222-8721-2021-11-3-37-44303Diagnostic criteria for spinal muscular atrophy 5qI. V. Sharkova0E. L. Dadali1S. S. Nikitin2Research Center of Medical GeneticsResearch Center of Medical GeneticsResearch Center of Medical GeneticsBackground. The variety of phenotypic manifestations of spinal muscular atrophy 5q (5qCMA) is the reason for the difficulty in diagnosing and delaying the diagnosis, which is of particular importance today due to the emergence of new etiopathogenetic therapeutic possibilities.Objective: determination of the main clinical features and symptoms of 5qCMA with onset at different age periods, and the development of an algorithm that can help in making decisions regarding the need for testing the SMN1 gene by primary care and hospital doctors.Materials and methods. A retrospective analysis of the case histories of patients observed at the Research Center of Medical Genetics with a confirmed diagnosis of 5qCMA was carried out.Results. The study included data from 315 patients, including: 173 with type I, 95 and 47 with types II and III 5qCMA. In all cases, the presence and diagnostic significance of 27 signs and symptoms were analyzed, depending on the age of disease manifestation. An attempt was made to isolate the main symptoms, which are the basis for the mandatory exclusion of 5qCMA by molecular genetic methods in patients with the onset of the disease before and after 18 months of life.https://nmb.abvpress.ru/jour/article/view/460spinal muscular atrophy5qcmasmn1 genediagnostic algorithm |
| spellingShingle | I. V. Sharkova E. L. Dadali S. S. Nikitin Diagnostic criteria for spinal muscular atrophy 5q Нервно-мышечные болезни spinal muscular atrophy 5qcma smn1 gene diagnostic algorithm |
| title | Diagnostic criteria for spinal muscular atrophy 5q |
| title_full | Diagnostic criteria for spinal muscular atrophy 5q |
| title_fullStr | Diagnostic criteria for spinal muscular atrophy 5q |
| title_full_unstemmed | Diagnostic criteria for spinal muscular atrophy 5q |
| title_short | Diagnostic criteria for spinal muscular atrophy 5q |
| title_sort | diagnostic criteria for spinal muscular atrophy 5q |
| topic | spinal muscular atrophy 5qcma smn1 gene diagnostic algorithm |
| url | https://nmb.abvpress.ru/jour/article/view/460 |
| work_keys_str_mv | AT ivsharkova diagnosticcriteriaforspinalmuscularatrophy5q AT eldadali diagnosticcriteriaforspinalmuscularatrophy5q AT ssnikitin diagnosticcriteriaforspinalmuscularatrophy5q |